All news

Pacira BioSciences (PCRX) complied with Nasdaq’s voluntary withdrawal rules.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Pacira BioSciences, Inc. (PCRX) has filed a Form 25 with Nasdaq for the voluntary withdrawal of its common stock from listing and registration. Nasdaq has certified that Pacira complied with the necessary rules and requirements for this voluntary withdrawal. This action signifies the company's delisting from the Nasdaq Stock Market.

Read original source

PCRX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.